Jove
Visualize
Contact Us

Related Concept Videos

Overview of Exosomes01:36

Overview of Exosomes

2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

4.7K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.7K
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
  1. Home
  3. Exosomes In Bone Cancer: Unveiling Their Vital Role In Diagnosis, Prognosis, And Therapeutic Advancements.
  1. Home
  3. Exosomes In Bone Cancer: Unveiling Their Vital Role In Diagnosis, Prognosis, And Therapeutic Advancements.

Related Experiment Video

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
11:15

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on: May 6, 2018

10.2K

Exosomes in Bone Cancer: Unveiling their Vital Role in Diagnosis, Prognosis, and Therapeutic Advancements.

Subhrojyoti Ghosh1, Atharva Anand Mahajan2, Anuvab Dey3

  • 1Department of Biotechnology, Indian Institute of Technology Madras, Chennai, Tamil Nadu 600036, India.

Journal of Cancer
|July 1, 2024

View abstract on PubMed

Summary
This summary is machine-generated.

Exosomes, tiny vesicles involved in cell communication, play a significant role in bone cancer progression. Researchers are exploring their potential for non-invasive diagnostics and targeted therapies in pediatric and adolescent bone cancers.

Keywords:
BiomarkersBone cancerExosomesExtracellular vesiclesLiquid biopsyPrecision medicineTumor microenvironment

More Related Videos

Using Nanoplasmon-Enhanced Scattering and Low-Magnification Microscope Imaging to Quantify Tumor-Derived Exosomes
09:30

Using Nanoplasmon-Enhanced Scattering and Low-Magnification Microscope Imaging to Quantify Tumor-Derived Exosomes

Published on: May 24, 2019

7.4K
Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool
08:49

Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool

Published on: May 27, 2016

11.1K

Related Experiment Videos

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
11:15

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on: May 6, 2018

10.2K
Using Nanoplasmon-Enhanced Scattering and Low-Magnification Microscope Imaging to Quantify Tumor-Derived Exosomes
09:30

Using Nanoplasmon-Enhanced Scattering and Low-Magnification Microscope Imaging to Quantify Tumor-Derived Exosomes

Published on: May 24, 2019

7.4K
Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool
08:49

Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool

Published on: May 27, 2016

11.1K

Area of Science:

  • Oncology
  • Cell Biology
  • Biochemistry

Background:

  • Bone cancer survival rates vary significantly with disease state, with localized forms having better prognoses than metastatic or recurrent ones.
  • Exosomes, initially considered waste carriers, are now understood as crucial mediators of intercellular communication, transporting biomolecules like proteins, DNA, and RNA.
  • The emerging role of exosomes in bone cancer progression, influencing tumorigenesis, metastasis, angiogenesis, immune evasion, and drug resistance, is a key area of research.

Purpose of the Study:

  • To review the biogenesis and sources of exosomes.
  • To explore the applications of exosomes in drug delivery and therapeutics for bone cancer.
  • To examine clinical trials on exosome cargo and discuss challenges and future directions in exosome research for cancer theranostics.

Main Methods:

  • Literature review of exosome biogenesis, function, and therapeutic applications in bone cancer.
  • Analysis of current research on exosome cargo in clinical trials.
  • Discussion of challenges and future research directions in the field.

Main Results:

  • Exosomes are increasingly recognized for their substantial potential in promoting bone cancer progression.
  • Exosomal biomarkers offer a non-invasive, cost-effective alternative to traditional diagnostic methods.
  • Exosomes hold promise for targeted drug delivery and novel therapeutic strategies.

Conclusions:

  • Exosomes are critical regulators of bone cancer progression, influencing multiple hallmarks of cancer.
  • Exosomal biomarkers present a significant opportunity for non-invasive, cost-effective cancer screening and diagnosis.
  • Further research into exosome biology and theranostics is essential for developing innovative solutions in bone cancer treatment.